Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0154950001
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Marketed | 02554178 | APOTEX INC | AFLIVU | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02554178 | APOTEX INC | AFLIVU | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02554194 | APOTEX INC | AFLIVU | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02554194 | APOTEX INC | AFLIVU | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Approved | 02562928 | VALORUM BIOLOGICS LLC | AHZANTIVE | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Approved | 02562928 | VALORUM BIOLOGICS LLC | AHZANTIVE | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02562510 | SANDOZ CANADA INCORPORATED | ENZEEVU | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02562510 | SANDOZ CANADA INCORPORATED | ENZEEVU | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Approved | 02562529 | SANDOZ CANADA INCORPORATED | ENZEEVU | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Approved | 02562529 | SANDOZ CANADA INCORPORATED | ENZEEVU | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02563037 | CELLTRION INC. | EYDENZELT | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02563037 | CELLTRION INC. | EYDENZELT | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Approved | 02563045 | CELLTRION INC. | EYDENZELT | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Approved | 02563045 | CELLTRION INC. | EYDENZELT | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02415992 | BAYER INC | EYLEA | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02415992 | BAYER INC | EYLEA | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02505355 | BAYER INC | EYLEA | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02505355 | BAYER INC | EYLEA | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Approved | 02561883 | SAMSUNG BIOEPIS CO., LTD | OPUVIZ | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Approved | 02561883 | SAMSUNG BIOEPIS CO., LTD | OPUVIZ | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Approved | 02561891 | SAMSUNG BIOEPIS CO., LTD | OPUVIZ | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Approved | 02561891 | SAMSUNG BIOEPIS CO., LTD | OPUVIZ | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Approved | 02550628 | AMGEN CANADA INC | PAVBLU | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Approved | 02550628 | AMGEN CANADA INC | PAVBLU | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02550636 | AMGEN CANADA INC | PAVBLU | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02550636 | AMGEN CANADA INC | PAVBLU | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02535858 | BIOCON BIOLOGICS CANADA INC | YESAFILI | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02535858 | BIOCON BIOLOGICS CANADA INC | YESAFILI | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02558238 | BIOCON BIOLOGICS CANADA INC | YESAFILI | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02558238 | BIOCON BIOLOGICS CANADA INC | YESAFILI | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
Application information
Related information
Contact us
Version 4.0.4